- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms of drug resistance in ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 6, Pages 4546-4562
Publisher
Wiley
Online
2017-11-20
DOI
10.1002/jcp.26289
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Pathways Offer Targets for Ovarian Cancer Treatment
- (2018) Melina-Theoni Gyparaki et al. Clinical Breast Cancer
- Updates of the role of oxidative stress in the pathogenesis of ovarian cancer
- (2017) Ghassan M. Saed et al. GYNECOLOGIC ONCOLOGY
- Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
- (2017) Allimuthu T. Dharmaraja JOURNAL OF MEDICINAL CHEMISTRY
- Nitroxide radical-containing nanoparticles as potential candidates for overcoming drug resistance in epidermoid cancers
- (2017) Babita Shashni et al. POLYMER
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma
- (2016) Wei Wei et al. CANCER CELL
- Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism
- (2016) Zhihong Ai et al. CANCER LETTERS
- Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk
- (2016) Dong Gui Hu et al. DRUG METABOLISM REVIEWS
- Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
- (2016) Xupeng Bai et al. DRUG METABOLISM REVIEWS
- Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
- (2016) Nicolette G. Alkema et al. DRUG RESISTANCE UPDATES
- A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
- (2016) Mckenna Longacre et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SiRNA and epigenetic aberrations in ovarian cancer
- (2016) HamidReza Mirzaei et al. Journal of Cancer Research and Therapeutics
- Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
- (2016) Huimin Bai et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
- (2016) Bowen Du et al. MOLECULES
- NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
- (2016) A R Özeş et al. ONCOGENE
- Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants
- (2016) Aysegul Cort et al. Oxidative Medicine and Cellular Longevity
- Understanding the Genetic Mechanisms of Cancer Drug Resistance Using Genomic Approaches
- (2016) Xueda Hu et al. TRENDS IN GENETICS
- Role of long non-coding RNA in tumor drug resistance
- (2016) Heng Deng et al. TUMOR BIOLOGY
- Molecular mechanisms of peritoneal dissemination in gastric cancer
- (2016) Mitsuro Kanda et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
- (2016) Chi Lam Au Yeung et al. Nature Communications
- Altered glutamine metabolism in platinum resistant ovarian cancer
- (2016) Chantelle D. Hudson et al. Oncotarget
- Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer
- (2015) Jane Borley et al. ANNALS OF MEDICINE
- miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation
- (2015) Delinaer Wuerkenbieke et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma
- (2015) Xiao Li et al. BMC CANCER
- Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer
- (2015) K-F Hsu et al. BRITISH JOURNAL OF CANCER
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Metabolic and mind shifts
- (2015) Cyril Corbet et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells
- (2015) Ryan Charles Pink et al. GYNECOLOGIC ONCOLOGY
- Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
- (2015) Glenn Simmons et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC)
- (2015) Ting Shuang et al. MEDICAL ONCOLOGY
- miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
- (2015) Marijn T. M. van Jaarsveld et al. Molecular Cancer
- NRP1 is targeted by miR-130a and miR-130b, and is associated with multidrug resistance in epithelial ovarian cancer based on integrated gene network analysis
- (2015) CHANGXIAN CHEN et al. Molecular Medicine Reports
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin
- (2015) X Zhu et al. ONCOGENE
- Molecular determinants of chemotherapy resistance in ovarian cancer
- (2015) Megan Cooley et al. PHARMACOGENOMICS
- Dysregulated metabolism contributes to oncogenesis
- (2015) Matthew D. Hirschey et al. SEMINARS IN CANCER BIOLOGY
- Uridine Diphosphate-Glucuronosyltransferase (UGT) Xenobiotic Metabolizing Activity and Genetic Evolution in Pinniped Species
- (2015) Mayu Kakehi et al. TOXICOLOGICAL SCIENCES
- DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma
- (2015) Noriko Yamaguchi et al. TUMOR BIOLOGY
- MicroRNA-9 promotes tumorigenesis and mediates sensitivity to cisplatin in primary epithelial ovarian cancer cells
- (2015) Hong-Min Zhao et al. TUMOR BIOLOGY
- MiR-197 induces Taxol resistance in human ovarian cancer cells by regulating NLK
- (2015) Dongling Zou et al. TUMOR BIOLOGY
- Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer
- (2015) Jing Li et al. TUMOR BIOLOGY
- MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88
- (2015) Yueping Zhan et al. Journal of Ovarian Research
- MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
- (2015) Kai-Xuan Sun et al. Journal of Ovarian Research
- The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
- (2015) Yingying Zhou et al. Journal of Ovarian Research
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma
- (2015) Euan A. Stronach et al. Oncotarget
- Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
- (2015) Rongrong Zhang et al. Stem Cell Research & Therapy
- Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
- (2015) Nirmala Chandralega Kampan et al. Biomed Research International
- Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells
- (2015) Karolina Weiner-Gorzel et al. Cancer Medicine
- Immunotherapeutic approaches to ovarian cancer treatment
- (2015) Cariad Chester et al. Journal for ImmunoTherapy of Cancer
- Aberrant DNA Damage Response Pathways May Predict the Outcome of Platinum Chemotherapy in Ovarian Cancer
- (2015) Dimitra T. Stefanou et al. PLoS One
- MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
- (2015) Ningwei Li et al. PLoS One
- SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α
- (2015) Qilin Ao et al. Scientific Reports
- Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
- (2014) L Sawers et al. BRITISH JOURNAL OF CANCER
- miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6
- (2014) Xiaolan Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells
- (2014) Juan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenes associated with drug resistance in ovarian cancer
- (2014) Xia Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin
- (2014) Carlos P. Huang et al. Metallomics
- Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
- (2014) HENAN ZHAO et al. ONCOLOGY REPORTS
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
- (2014) Aditya Parikh et al. Nature Communications
- A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
- (2014) Da Li et al. Scientific Reports
- A Paradoxical Chemoresistance and Tumor Suppressive Role of Antioxidant in Solid Cancer Cells: A Strange Case of Dr. Jekyll and Mr. Hyde
- (2014) Jolie Kiemlian Kwee Biomed Research International
- Apoptosis and Molecular Targeting Therapy in Cancer
- (2014) Mohamed Hassan et al. Biomed Research International
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
- (2014) Deborah J. Marsh et al. Frontiers in Oncology
- Targeted therapies and clinical trials in ovarian cancer
- (2013) J. Dancey ANNALS OF ONCOLOGY
- Role of Nrf2 in Oxidative Stress and Toxicity
- (2013) Qiang Ma Annual Review of Pharmacology and Toxicology
- Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
- (2013) J H Huh et al. BRITISH JOURNAL OF CANCER
- Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
- (2013) F. Baenke et al. Disease Models & Mechanisms
- Function of oncogenes in cancer development: a changing paradigm
- (2013) Carolina Vicente-Dueñas et al. EMBO JOURNAL
- Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells
- (2013) Pei-Ning Yu et al. INTERNATIONAL JOURNAL OF CANCER
- Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
- (2013) Carmen Pyragius et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas
- (2013) Yu-Quan Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients
- (2013) Akira Hirasawa et al. JOURNAL OF HUMAN GENETICS
- Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics
- (2013) C. S. Lancaster et al. MOLECULAR CANCER THERAPEUTICS
- Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
- (2013) S. Portmann et al. MOLECULAR CANCER THERAPEUTICS
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine
- (2013) Y Xiang et al. ONCOGENE
- Upregulation of NEK2 is associated with drug resistance in ovarian cancer
- (2013) XIA LIU et al. ONCOLOGY REPORTS
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
- (2013) Jonathan T. Sims et al. PLoS One
- Transcriptional Suppression, DNA Methylation, and Histone Deacetylation of the Regulator of G-Protein Signaling 10 (RGS10) Gene in Ovarian Cancer Cells
- (2013) Mourad W. Ali et al. PLoS One
- SNAI1-Mediated Epithelial-Mesenchymal Transition Confers Chemoresistance and Cellular Plasticity by Regulating Genes Involved in Cell Death and Stem Cell Maintenance
- (2013) Soyoung Lim et al. PLoS One
- The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression
- (2013) Zhili Liu et al. PLoS One
- The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer
- (2013) Jimmy Belotte et al. Reproductive Sciences
- Nucleotide Excision Repair in Eukaryotes
- (2013) O. D. Scharer Cold Spring Harbor Perspectives in Biology
- Targeting cellular metabolism to improve cancer therapeutics
- (2013) Y Zhao et al. Cell Death & Disease
- miR-21 modulates paclitaxel sensitivity and hypoxia-inducible factor-1α expression in human ovarian cancer cells
- (2013) ZHONGBIN XIE et al. Oncology Letters
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET
- (2013) T Mitamura et al. Oncogenesis
- Metabolic changes in cancer: beyond the Warburg effect
- (2012) W. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
- (2012) Ahmed Y. Ali et al. Annals of the New York Academy of Sciences
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- BRCA1epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
- (2012) Olafur A. Stefansson et al. Epigenetics
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility
- (2012) D. Ziliak et al. MOLECULAR CANCER THERAPEUTICS
- Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity
- (2012) Tao Zhang et al. Molecular Informatics
- Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells
- (2012) N Chapman-Rothe et al. ONCOGENE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling
- (2012) C Zeller et al. ONCOGENE
- Involvement of autophagy in ovarian cancer: a working hypothesis
- (2012) Claudia Peracchio et al. Journal of Ovarian Research
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells
- (2011) L. Rosano et al. CLINICAL CANCER RESEARCH
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications
- (2011) S. E. Polo et al. GENES & DEVELOPMENT
- Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
- (2011) Chun Yang et al. GYNECOLOGIC ONCOLOGY
- MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance
- (2011) G. Ye et al. JOURNAL OF CELL SCIENCE
- miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1
- (2011) Fanfei Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Expression of OATP Family Members in Hormone-Related Cancers: Potential Markers of Progression
- (2011) Heather Pressler et al. PLoS One
- Melatonina: modulador de morte celular
- (2011) Cecília da Silva Ferreira et al. Revista da Associacao Medica Brasileira
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
- (2010) Alex Chang LUNG CANCER
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
- (2010) S. B. Howell et al. MOLECULAR PHARMACOLOGY
- The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer
- (2010) L. D. Kellenberger et al. Journal of Oncology
- Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
- (2010) Chung-Pu Wu et al. Current Molecular Pharmacology
- Epithelial–mesenchymal transition in ovarian cancer
- (2009) Daniele Vergara et al. CANCER LETTERS
- MicroRNAs in ovarian carcinomas
- (2009) Neetu Dahiya et al. ENDOCRINE-RELATED CANCER
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress
- (2009) Truyen Nguyen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α
- (2009) Lei Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
- (2009) Tristan M. Sissung et al. MOLECULAR BIOTECHNOLOGY
- Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance
- (2009) E. A. Perez MOLECULAR CANCER THERAPEUTICS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
- (2008) Ralph J Deberardinis GENETICS IN MEDICINE
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started